The impact of full reimbursement of flash glucose monitoring on Czech patients - experience of one diabetes center

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F24%3A10481292" target="_blank" >RIV/00064203:_____/24:10481292 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/24:10481292 RIV/00216208:11230/24:10481292

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=KGh7cliKiL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=KGh7cliKiL</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.32725/kont.2024.028" target="_blank" >10.32725/kont.2024.028</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The impact of full reimbursement of flash glucose monitoring on Czech patients - experience of one diabetes center

Popis výsledku v původním jazyce

The introduction of glucose sensors has been a major shift in glycemic self-monitoring. The aim of the study was to analyze the medical effect of Flash Glucose Monitoring (FGM) in type 1 diabetes patients at our clinic, in the context of the introduction of full reimbursement of FGM technology from public health insurance. We studied 64 women and 51 men (median age 42 years). All patients were treated with an intensified insulin regimen. No previous experience with any glucose sensors was reported by 61 patients (43%). Data on diabetes control prior to the introduction of the full FGM reimbursement (2019) and 12 months later (2020) were compared. Additionally, costeffectiveness analysis was done. Diabetes control improved significantly (p = 0.001 for HbA1c interannual decrease). Results were influenced mainly by the number of applied sensors; surprisingly only 30 patients (29.6%) used all covered sensors. If we consider, for example, a decrease of the risk of the progression of diabetic kidney disease to the end stage of chronic renal failure by 1/3 (due to diabetes control improvement which is achieved by using glucose sensors), there will also be an economic benefit as the cost-effectiveness ratio was calculated for this model situation 6 and the net cost of USD 7,281. The financial barrier is clearly not the only barrier to the widespread use of modern technologies. The results of the study led to the implementation of long-term nudge strategies targeted at both patients and health professionals in our center to improve patients&apos; prognosis.

Název v anglickém jazyce

The impact of full reimbursement of flash glucose monitoring on Czech patients - experience of one diabetes center

Popis výsledku anglicky

The introduction of glucose sensors has been a major shift in glycemic self-monitoring. The aim of the study was to analyze the medical effect of Flash Glucose Monitoring (FGM) in type 1 diabetes patients at our clinic, in the context of the introduction of full reimbursement of FGM technology from public health insurance. We studied 64 women and 51 men (median age 42 years). All patients were treated with an intensified insulin regimen. No previous experience with any glucose sensors was reported by 61 patients (43%). Data on diabetes control prior to the introduction of the full FGM reimbursement (2019) and 12 months later (2020) were compared. Additionally, costeffectiveness analysis was done. Diabetes control improved significantly (p = 0.001 for HbA1c interannual decrease). Results were influenced mainly by the number of applied sensors; surprisingly only 30 patients (29.6%) used all covered sensors. If we consider, for example, a decrease of the risk of the progression of diabetic kidney disease to the end stage of chronic renal failure by 1/3 (due to diabetes control improvement which is achieved by using glucose sensors), there will also be an economic benefit as the cost-effectiveness ratio was calculated for this model situation 6 and the net cost of USD 7,281. The financial barrier is clearly not the only barrier to the widespread use of modern technologies. The results of the study led to the implementation of long-term nudge strategies targeted at both patients and health professionals in our center to improve patients&apos; prognosis.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30307 - Nursing

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Kontakt

ISSN

1212-4117

e-ISSN

1804-7122

Svazek periodika

26

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

10

Strana od-do

198-207

Kód UT WoS článku

001239963200015

EID výsledku v databázi Scopus

2-s2.0-85197588201